tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
Holding GANX?
Track your performance easily

Gain Therapeutics (GANX) Cash flow

221 Followers

Gain Therapeutics Cash Flow

GANX's free cash flow for Q2 2024 was $-5.78M. For the 2024 fiscal year, GANX's free cash flow was decreased by $-4.07M and operating cash flow was $-5.76M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -18.97M$ -18.87M$ -14.69M$ -12.37M$ -3.24M$ -1.87M
Investing Cash Flow
$ 10.09M$ 10.22M$ -14.77M$ -94.21K$ -20.83K$ -13.72K
Financing Cash Flow
$ 19.59M$ 12.64M$ -78.77K$ 41.77M$ 10.49M$ 1.75M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 38.63M$ 11.83M$ 7.34M$ 36.91M$ 7.50M$ 313.70K
Income Tax Paid Supplemental Data
$ 134.96K$ 134.96K$ 2.74K$ 4.47K$ 4.57K$ 9.44K
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 554.75K$ 3.54M-$ 42.63M$ 10.22M$ 1.75M
Issuance Of Debt
$ -90.19K$ -89.07K$ -78.77K$ -21.95K$ 738.28K$ 0.00
Repayment Of Debt
$ -90.19K$ -89.07K$ -78.77K$ -21.95K$ 0.00-
Free Cash Flow
$ -18.99M$ -18.88M$ -14.81M$ -12.46M$ -3.26M$ -1.88M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Gain Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis